Cargando…

130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States

BACKGROUND: Multidrug-resistant (MDR) Shigella sonnei infections are a serious public health threat, and outbreaks are common among men who have sex with men (MSM). In February 2020, Australia’s Department of Health notified CDC of extensively drug-resistant (XDR) S. sonnei in 2 Australian residents...

Descripción completa

Detalles Bibliográficos
Autores principales: Logan, Naeemah Z, Karp, Beth E, Tagg, Kaitlin A, Burns-Lynch, Claire, Chen, Jessica, Garcia-Williams, Amanda, Marsh, Zachary A, O’Laughlin, Kevin, Plumb, Ian D, Schroeder, Morgan N, Webb, Hattie E, Zenas, Hannah, Draper, Jenny, Ginn, Andrew, Martinez, Elena, Partridge, Sally R, Sim, Eby, Sintchenko, Vitali, Iredell, Jonathan, Watkins, Louise Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776455/
http://dx.doi.org/10.1093/ofid/ofaa439.440
_version_ 1783630687437324288
author Logan, Naeemah Z
Karp, Beth E
Tagg, Kaitlin A
Burns-Lynch, Claire
Chen, Jessica
Garcia-Williams, Amanda
Marsh, Zachary A
O’Laughlin, Kevin
Plumb, Ian D
Schroeder, Morgan N
Webb, Hattie E
Zenas, Hannah
Draper, Jenny
Ginn, Andrew
Martinez, Elena
Partridge, Sally R
Sim, Eby
Sintchenko, Vitali
Iredell, Jonathan
Watkins, Louise Francois
author_facet Logan, Naeemah Z
Karp, Beth E
Tagg, Kaitlin A
Burns-Lynch, Claire
Chen, Jessica
Garcia-Williams, Amanda
Marsh, Zachary A
O’Laughlin, Kevin
Plumb, Ian D
Schroeder, Morgan N
Webb, Hattie E
Zenas, Hannah
Draper, Jenny
Ginn, Andrew
Martinez, Elena
Partridge, Sally R
Sim, Eby
Sintchenko, Vitali
Iredell, Jonathan
Watkins, Louise Francois
author_sort Logan, Naeemah Z
collection PubMed
description BACKGROUND: Multidrug-resistant (MDR) Shigella sonnei infections are a serious public health threat, and outbreaks are common among men who have sex with men (MSM). In February 2020, Australia’s Department of Health notified CDC of extensively drug-resistant (XDR) S. sonnei in 2 Australian residents linked to a cruise that departed from Florida. We describe an international outbreak of XDR S. sonnei and report on trends in MDR among S. sonnei in the United States. METHODS: Health departments (HDs) submit every 20th Shigella isolate to CDC’s National Antimicrobial Resistance Monitoring System (NARMS) laboratory for susceptibility testing. We defined MDR as decreased susceptibility to azithromycin (MIC ≥32 µg/mL) with resistance to ampicillin, ciprofloxacin, and cotrimoxazole, and XDR as MDR with additional resistance to ceftriaxone. We used PulseNet, the national subtyping network for enteric disease surveillance, to identify US isolates related to the Australian XDR isolates by short-read whole genome sequencing. We screened these isolates for resistance determinants (ResFinder v3.0) and plasmid replicons (PlasmidFinder) and obtained patient histories from HDs. We used long-read sequencing to generate closed plasmid sequences for 2 XDR isolates. RESULTS: NARMS tested 2,781 S. sonnei surveillance isolates during 2011–2018; 80 (2.9%) were MDR, including 1 (0.04%) that was XDR. MDR isolates were from men (87%), women (9%), and children (4%). MDR increased from 0% in 2011 to 15.3% in 2018 (Figure). In 2020, we identified XDR isolates from 3 US residents on the same cruise as the Australians. The US residents were 41–42 year-old men; 2 with available information were MSM. The US and Australian isolates were highly related (0–1 alleles). Short-read sequence data from all 3 US isolates mapped to the bla(CTX-M-27) harboring IncFII plasmids from the 2 Australian isolates with >99% nucleotide identity. bla(CTX-M-27) genes confer ceftriaxone resistance. Increase in Percentage of Shigella sonnei Isolates with Multidrug Resistance* in the United States, 2011–2018† [Image: see text] CONCLUSION: MDR S. sonnei is increasing and is most often identified among men. XDR S. sonnei infections are emerging and are resistant to all recommended antibiotics, making them difficult to treat without IV antibiotics. This outbreak illustrates the alarming capacity for XDR S. sonnei to disseminate globally among at-risk populations, such as MSM. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7776455
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77764552021-01-07 130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States Logan, Naeemah Z Karp, Beth E Tagg, Kaitlin A Burns-Lynch, Claire Chen, Jessica Garcia-Williams, Amanda Marsh, Zachary A O’Laughlin, Kevin Plumb, Ian D Schroeder, Morgan N Webb, Hattie E Zenas, Hannah Draper, Jenny Ginn, Andrew Martinez, Elena Partridge, Sally R Sim, Eby Sintchenko, Vitali Iredell, Jonathan Watkins, Louise Francois Open Forum Infect Dis Poster Abstracts BACKGROUND: Multidrug-resistant (MDR) Shigella sonnei infections are a serious public health threat, and outbreaks are common among men who have sex with men (MSM). In February 2020, Australia’s Department of Health notified CDC of extensively drug-resistant (XDR) S. sonnei in 2 Australian residents linked to a cruise that departed from Florida. We describe an international outbreak of XDR S. sonnei and report on trends in MDR among S. sonnei in the United States. METHODS: Health departments (HDs) submit every 20th Shigella isolate to CDC’s National Antimicrobial Resistance Monitoring System (NARMS) laboratory for susceptibility testing. We defined MDR as decreased susceptibility to azithromycin (MIC ≥32 µg/mL) with resistance to ampicillin, ciprofloxacin, and cotrimoxazole, and XDR as MDR with additional resistance to ceftriaxone. We used PulseNet, the national subtyping network for enteric disease surveillance, to identify US isolates related to the Australian XDR isolates by short-read whole genome sequencing. We screened these isolates for resistance determinants (ResFinder v3.0) and plasmid replicons (PlasmidFinder) and obtained patient histories from HDs. We used long-read sequencing to generate closed plasmid sequences for 2 XDR isolates. RESULTS: NARMS tested 2,781 S. sonnei surveillance isolates during 2011–2018; 80 (2.9%) were MDR, including 1 (0.04%) that was XDR. MDR isolates were from men (87%), women (9%), and children (4%). MDR increased from 0% in 2011 to 15.3% in 2018 (Figure). In 2020, we identified XDR isolates from 3 US residents on the same cruise as the Australians. The US residents were 41–42 year-old men; 2 with available information were MSM. The US and Australian isolates were highly related (0–1 alleles). Short-read sequence data from all 3 US isolates mapped to the bla(CTX-M-27) harboring IncFII plasmids from the 2 Australian isolates with >99% nucleotide identity. bla(CTX-M-27) genes confer ceftriaxone resistance. Increase in Percentage of Shigella sonnei Isolates with Multidrug Resistance* in the United States, 2011–2018† [Image: see text] CONCLUSION: MDR S. sonnei is increasing and is most often identified among men. XDR S. sonnei infections are emerging and are resistant to all recommended antibiotics, making them difficult to treat without IV antibiotics. This outbreak illustrates the alarming capacity for XDR S. sonnei to disseminate globally among at-risk populations, such as MSM. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7776455/ http://dx.doi.org/10.1093/ofid/ofaa439.440 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Logan, Naeemah Z
Karp, Beth E
Tagg, Kaitlin A
Burns-Lynch, Claire
Chen, Jessica
Garcia-Williams, Amanda
Marsh, Zachary A
O’Laughlin, Kevin
Plumb, Ian D
Schroeder, Morgan N
Webb, Hattie E
Zenas, Hannah
Draper, Jenny
Ginn, Andrew
Martinez, Elena
Partridge, Sally R
Sim, Eby
Sintchenko, Vitali
Iredell, Jonathan
Watkins, Louise Francois
130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States
title 130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States
title_full 130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States
title_fullStr 130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States
title_full_unstemmed 130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States
title_short 130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States
title_sort 130. increase in multidrug resistance (2011–2018) and the emergence of extensive drug resistance (2020) in shigella sonnei in the united states
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776455/
http://dx.doi.org/10.1093/ofid/ofaa439.440
work_keys_str_mv AT logannaeemahz 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT karpbethe 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT taggkaitlina 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT burnslynchclaire 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT chenjessica 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT garciawilliamsamanda 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT marshzacharya 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT olaughlinkevin 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT plumbiand 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT schroedermorgann 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT webbhattiee 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT zenashannah 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT draperjenny 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT ginnandrew 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT martinezelena 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT partridgesallyr 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT simeby 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT sintchenkovitali 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT iredelljonathan 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates
AT watkinslouisefrancois 130increaseinmultidrugresistance20112018andtheemergenceofextensivedrugresistance2020inshigellasonneiintheunitedstates